'We can end HIV': Groundbreaking preventative drug to be rolled out for $40 a year from 2027 – France 24
- ‘We can end HIV’: Groundbreaking preventative drug to be rolled out for $40 a year from 2027 France 24
- Lenacapavir: Landmark deal paves way for cheaper HIV/ Aids protection jab BBC
- Indian generic pharma firms at centre of global push to end HIV TRT World
- Generics makers to sell Gilead’s Yeztugo at $40 a year under deals with Gates Foundation, others Fierce Pharma
- New partnerships bring price parity between lenacapavir and oral PrEP Devex